In terms of Regulation 42 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Medicamen Biotech has informed that the Register of Members and Share Transfer Books of the Company shall remain closed from Friday, 20th September, 2024 to Thursday, 26th September, 2024 for the purpose of 31st AGM of the Company and payment of final dividend. The Company has fixed Thursday, 19th September, 2024 as the 'Record Date' for determining entitlement of members to receive final dividend for the FY 2023-24. The final dividend for the financial year 2023-24, if declared at the 31st AGM, will be paid within the stipulated time, to all those members whose names appear on the Company's Register of Members / Beneficial Owners as at the closure of business hours on Thursday, 19th September, 2024 as the 'Record Date'. The above intimation will also be available on the Company's website at www.medicamen.com.
The above information is a part of company’s filings submitted to BSE.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: